Results 31 to 40 of about 91,065 (316)
Application of Novel Psychoactive Substances: Chemsex and HIV/AIDS Policies Among Men Who Have Sex With Men in Hong Kong. [PDF]
Front Psychiatry, 2021 Chan ASW, Tang PMK.
europepmc +2 more sources
Novel psychoactive substance [PDF]
Clinical Medicine, 2021 Editor – We read with interest the article entitled ‘Acute neurological consequences of novel psychoactive substance use: a retrospective review in a large UK hospital’ by Tanti et al .[1][1] The team have effectively highlighted the high rates of psychiatric comorbidity, unemployment,
Mark, Pucci +2 more
openaire +2 more sources
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2017 There has been a significant increase in the number of new intoxicants on the illegal drugs market globally, also in Norway. The substances are given the name NPS: Novel Psychoactive Substances, and are mainly sold over the Internet. Uncertain dosage of potent substances entails a risk of accidental overdose, and therefore serious intoxication and ...
M.T. Zanda, L. Fattore
+6 more sources
Substance use in the club scene of Rome : a pilot study [PDF]
, 2014 Date of Acceptance: 28/08/2014 Copyright © 2014 Alessandro Emiliano Vento et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium ...
Acciavatti, Tiziano +11 more
core +13 more sources
The Use and Impact of Cognitive Enhancers among University Students: A Systematic Review
Brain Sciences, 2021 Introduction: Cognitive enhancers (CEs), also known as “smart drugs”, “study aids” or “nootropics” are a cause of concern. Recent research studies investigated the use of CEs being taken as study aids by university students.
Safia Sharif +3 more
doaj +1 more source
Brain Sciences, 2023 The emergence of glucagon-like peptide-1 receptor agonists (GLP-1 RAs; semaglutide and others) now promises effective, non-invasive treatment of obesity for individuals with and without diabetes.
Davide Arillotta +7 more
doaj +1 more source
Identifying New/Emerging Psychoactive Substances at the Time of COVID-19; A Web-Based Approach
Frontiers in Psychiatry, 2021 COVID-19-related disruptions of people and goods' circulation can affect drug markets, especially for new psychoactive substances (NPSs). Drug shortages could cause a change in available NPS, with the introduction of new, unknown, substances. The aims of
Valeria Catalani +8 more
doaj +1 more source
COVID-19 Pandemic Impact on Substance Misuse: A Social Media Listening, Mixed Method Analysis
Brain Sciences, 2021 The restrictive measures adopted during the COVID-19 pandemic modified some previously consolidated drug use patterns. A focus on social networks allowed drug users to discuss, share opinions and provide advice during a worldwide emergency context.
Davide Arillotta +4 more
doaj +1 more source
Pharmaceuticals, 2021 Designer benzodiazepines (DBZDs) represent a serious health concern and are increasingly reported in polydrug consumption-related fatalities. When new DBZDs are identified, very limited information is available on their pharmacodynamics.
Valeria Catalani +6 more
doaj +1 more source
The International journal on drug policy, 2023 BACKGROUND The proliferation of Novel Psychoactive Substances (NPS) presents a challenge for global drug policy. The ease of online drug purchase and the emergence of the dark web have created new avenues for the growth of NPS.
Tayler Holborn, F. Schifano, P. Deluca
semanticscholar +1 more source